It is the one with the most experience on the market in the development of specific protocols for tissue regeneration, a pioneering closed system technique developed exclusively by BTI Biotechnology Institute.< Regenerative Medicine
Plasma obtained from the blood using systems like Endoret technology contains an optimised concentration of platelets that, in their therapeutic application, produces the release of proteins, such as growth factors, that improve healing and clinical treatment, improving the results of standard treatments as well as making it possible to treat more complex illnesses and interventions with a greater incidence of success.
Thanks to its versatility, Endoret Technology allows to obtain different formulations of the product that can be adapted to different clinical uses
Endoret PRGF is a closed system, with the necessary equipment and unitary and disposable kits certified for such use that allows a rapid preparation of plasma under sterile conditions and its immediate application.
On the 23rd of May, 2013, the Spanish Medicine Agency stated that plasmas rich in platelets are now medicines for human use. Since then, the use of PRPs was reliant on the health regulation with two techniques for obtaining them: the open or closed technique.
What's the difference between the closed and the open technique?
In the closed technique, the method for obtaining PRP is by means of disposable, single-use kits; the instructions given by the manufacturer of each system must be followed without it being necessary to obtain a certificate of adequacy from the facilities. In the open technique, the method for obtaining PRP should be evaluated and authorised by an inspection by the competent health regulation to verify the suitability of the facilities and the production activities.
Endoret® (PRGF®) falls under the category that uses disposable kits, that is, the "closed technique". As required in AEMPS, the Endoret kit has the CE certification, issued for tissue regeneration. The kit contains all of the elements required for obtaining plasma rich in growth factors formulations, without needing to use external elements.